Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Intraoperative Radiotherapy United States (TARGIT-US) Phase IV Registry Trial: A Registry Trial of Targeted Intraoperative Radiation Therapy Following Breast-conserving Surgery

NCT01570998 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01570998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01570998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Intraoperative Radiotherapy United States (TARGIT-US) Phase IV Registry Trial: A Registry Trial of Targeted Intraoperative Radiation Therapy Following Breast-conserving Surgery
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 18, 2012
Completion date
December 31, 2028
Enrollment
1,259 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

stage ia breast cancer, stage iia breast cancer